In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced BioPhotonics enters trial agreement with Beth Israel Deaconess:

This article was originally published in Clinica

Executive Summary

Imaging firm Advanced BioPhotonics has entered into a pilot research agreement with the Beth Israel Deaconess Medical Center (BIDMC) - a teaching hospital of Harvard Medical School. As part of the agreement, BIDMC will be carrying out a clinical trial of the company's patented BioScanIR system, which it says provides a fast, noninvasive, radiation-free method for detecting diseases that affect perfusion and reperfusion in human tissue. The first phase of the trial is scheduled to begin in September 2007, said the Bohemia, New York-based company. The BioScanIR system uses the firm's proprietary DIRI - dynamic infrared imaging - technology, which has been developed for detecting and assessing pigmented lesions of the skin including melanoma and other forms of skin cancer.

You may also be interested in...

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts